geodesic.com.au
Geodesic Systems Pty Ltd
http://geodesic.com.au/common/pca.html
Geodesic Systems Pty Ltd. ACN 068 978 183. Geodesic Systems Pty Ltd. Is a software engineering consulting company specialising in the provision of software engineering and management services to the defence, security, communications, aerospace and storage industries. Geodesic Systems has been operating since 1995 and has provided specialist engineering services to such clients as Raytheon. Then Hughes Aircraft Corporation), SaabSystems. Then CelsiusTech), BAE Systems Australia. Geodesic Systems Pty Ltd.
calpaintherapeutics.com
People | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/people
Calpain Therapeutics The Vision Protection Company. Tim Lovell, PhD, MBA, GAICD:. Hugo LeMessurier BSc(Hons), GAICD:. Matthew Worrell, CPA:. Matthew is the company Secretary and founded Worrell and Co in 2003 and has been working in the accounting industry for the last 21 years. He is a certified practising accountant and specialises in business consulting, self-managed super funds and taxation. Professor Andrew Abell, PhD:. Professor Evan Siegel, PhD:. Andrew Bollen, PhD:. Des Williamns, PhD:. For all e...
calpaintherapeutics.com
Technology | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/tech
Calpain Therapeutics The Vision Protection Company. Proprietary Chemical Compound Library. Calpains are a family of ubiquitously-expressed, calcium-dependent, non-lysosomal cysteine proteases which are present in the cells of many optic and neuronal tissues. There are two major isoforms of this family of proteases - Calpain 1 and Calpain 2. Calpains are activated by an influx of calcium ions into cells, with Calpain 1 requiring less calcium for activation than Calpain 2. Calpain Therapeutics has exclusiv...
calpaintherapeutics.com
Business | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/business
Calpain Therapeutics The Vision Protection Company. Calpain Therapeutics is developing a library of proprietary compounds to treat ophthalmic diseases representing major causes of blindness and unmet medical needs globally. The number of people in the world suffering from cataract is predicted to increase due to growing and ageing populations. While cataract can be treated by surgery, the current surgical capacity on a global scale is insufficient to meet the anticipated future demand. The primary treatm...
calpaintherapeutics.com
About | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/about
Calpain Therapeutics The Vision Protection Company. Based in Adelaide, Australia, Calpain Therapeutics Pty Ltd is a privately-funded biotechnology venture dedicated to the development of proprietary candidate drug compounds having the potential to impact the progression of major ophthalmic diseases and enhance the quality of patients' lives. For all enquiries and to make contact, please use the Contact Us button at the top of each page of the website, or, email tim@calpaintherapeutics.com.
calpaintherapeutics.com
Pipeline | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/pipeline
Calpain Therapeutics The Vision Protection Company. Calpain Therapeutics is examining the potential for it’s proprietary library of compounds to treat unmet medical needs, relevant for both front and back of the eye diseases. CAT1001 is a pre-clinical compound being developed with specificity for Calpain 1 and Calpain 2. This molecule is shortly to undergo pre-clinical studies in a proprietary human retina model and in a well-established animal model of Glaucoma to confirm it confers protection on re...
calpaintherapeutics.com
News | Calpain Therapeutics - The Vision Protection Company
http://www.calpaintherapeutics.com/blog
Calpain Therapeutics The Vision Protection Company. Meet Calpain Therapeutics in 2015. Calpains CEO Interviewed By Surani Fernando From BioPharmaInsight In London. Calpain Therapeutics Secures Private Investment To Progress Anti-Cataract Programme. Calpain Therapeutics Wins Commercialisation Australia Grant To Progress Anti-Cataract Programme. Time To Recognise The Heroes Of Commerce. Calpain Therapeutics Is $100,000 Enterprize Winner. New Drug Eyes Way To Beat Cataracts. Meet Calpain Therapeutics in 2015.